The Form 4 filing was submitted on October 29, 2026, for an October 27 trade. This SEC report records changes in an insider's stock ownership. Traci S. Umberger is Kestra Medical Technologies' general counsel and chief administrative officer.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-27 |
| Date of Latest Transaction | 2026-10-27 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 30,000 |
| Price | $30.03 |
| Total Transaction Value | $900,882.00 |
| Insider | |
| Ticker Symbol | KMTS |
| Company | KESTRA MEDICAL TECHNOLOGIES, LTD. |
| Insider Name | Umberger Traci S |
| Insider Title | General Counsel and Chief Adminstrative Officer |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 195,825 |
| Position Size Change | 13.28% |
| Filing | |
| Filing Date | 2026-10-29 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of KMTS shares under transaction code S. One sale transaction was reported. The details also link the sale to an exercise or conversion.
What was the average price of the transaction?
The average sale price was $30.0294 per share. Rounded to cents, that is $30.03.
How did this transaction affect the insider's holdings?
She sold 30,000 shares and reported 195,825 shares owned afterward. The sale covered 13.28% of her reported shares before the trade.
What's the total transaction value?
The total sale value was $900,882.00 for the 30,000 shares.
Are there any special circumstances around this transaction?
The transaction details include a Rule 10b5-1 trading-plan reference. Such plans set trading instructions in advance. Footnote text was not available to confirm whether the plan covered this sale.
The sale was also linked by share count to an exercise or conversion in the same filing. That can mean using a right to buy stock or turning another security into shares. The matching entry and footnotes were not available to check the dates, accounts, or whether the same shares were sold.
For research purposes only; not investment advice.